Results 201 to 210 of about 1,181,836 (211)
Some of the next articles are maybe not open access.
Efficacy and safety of CT-P13 (infliximab biosimilar) over two years in patients with ankylosing spondylitis: comparison between continuing with CT-P13 and switching from infliximab to CT-P13
Arthritis & Rheumatism, 2013 Park, Won, Miranda, Pedro, Brzosko, Marek, Gutierrez-Urena, Sergio, Mikazane, Helena, Lee, Yeon-Ah, Smiyan, Svitlana, Lim, Mie-Jin, Kadinov, Vladimir, Abud-Mendoza, Carlos, Son, YoungKi, Yoo, Dae-Hyun, Braun, Jurgen +12 moreopenaire A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry
Annals of the Rheumatic Diseases, 2017 B. Glintborg, I. Sørensen, A. Loft, H. Lindegaard, A. Linauskas, O. Hendricks, I. Hansen, D. Jensen, N. Manilo, J. Espesen, M. Klarlund, J. Grydehøj, S. Dieperink, S. Kristensen, Jimmi S Olsen, H. Nordin, S. Chrysidis, Dorte Dalsgaard Pedersen, M. Sørensen, L. Andersen, K. Grøn, N. Krogh, L. Pedersen, M. Hetland +23 moresemanticscholar +1 more source